• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核间性眼肌麻痹在多发性硬化症人群中基于人群的队列中的患病率。

The prevalence of internuclear ophthalmoparesis in a population-based cohort of individuals with multiple sclerosis.

机构信息

Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurology, MS Center and Neuro-ophthalmology Expertise Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurology, MS Center and Neuro-ophthalmology Expertise Center Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

出版信息

Mult Scler Relat Disord. 2022 Jul;63:103824. doi: 10.1016/j.msard.2022.103824. Epub 2022 Apr 25.

DOI:10.1016/j.msard.2022.103824
PMID:35490450
Abstract

BACKGROUND

Internuclear ophthalmoparesis (INO) occurs in 15-52% of individuals with multiple sclerosis (MS) and is reliably detected by infrared oculography. Methods for diagnosing INO with infrared oculography and the association between INO and MS characteristics need confirmation. We aimed to describe INO prevalence and the clinical characteristics of individuals with MS and INO in a population-based cohort of individuals with MS born in the year 1966 (Project Y).

METHODS

Previously described thresholds for the versional dysconjugacy index (VDI), assessed with standardized infrared oculography, were used to detect INO in participants of project Y. Clinical characteristics, visual functioning and complaints were compared between individuals with MS with INO and individuals with MS without INO.

RESULTS

Two-hundred-twenty individuals with MS and 110 healthy controls were included. VDI values exceeding the threshold for INO presented in 53 (24%) individuals with MS and 19 controls (13%). INO was associated with male sex, greater disability, worse cognition and worse arm function in individuals with MS. There was no association with disease duration, visual functioning or complaints.

CONCLUSIONS

INO is prevalent among individuals with MS aged fifty-three and related to clinical characteristics of MS. INO was more frequently detected in healthy controls than previous studies, implying that oculography based diagnosis of INO requires further refinement.

摘要

背景

核间性眼肌麻痹(INO)在 15-52%的多发性硬化症(MS)患者中发生,通过红外眼动描记术可可靠地检测到。需要确认使用红外眼动描记术诊断 INO 的方法以及 INO 与 MS 特征之间的关联。我们旨在描述基于人群的 1966 年出生的 MS 患者队列(项目 Y)中 INO 的患病率以及 INO 患者的 MS 临床特征。

方法

先前描述的用于评估视差失调指数(VDI)的阈值,通过标准化的红外眼动描记术进行评估,用于检测项目 Y 参与者中的 INO。比较 INO 患者与无 INO 患者的 MS 临床特征、视觉功能和症状。

结果

共纳入 220 名 MS 患者和 110 名健康对照者。53 名(24%)MS 患者和 19 名对照者(13%)的 VDI 值超过 INO 的阈值。INO 与 MS 患者中的男性、更高的残疾程度、更差的认知和手臂功能有关。与疾病持续时间、视觉功能或症状无关。

结论

INO 在 53 岁的 MS 患者中较为常见,与 MS 的临床特征相关。INO 在健康对照者中的检出率高于既往研究,这意味着基于眼动描记术的 INO 诊断需要进一步改进。

相似文献

1
The prevalence of internuclear ophthalmoparesis in a population-based cohort of individuals with multiple sclerosis.核间性眼肌麻痹在多发性硬化症人群中基于人群的队列中的患病率。
Mult Scler Relat Disord. 2022 Jul;63:103824. doi: 10.1016/j.msard.2022.103824. Epub 2022 Apr 25.
2
Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia.诊断和量化多发性硬化症的常见缺陷:眼肌神经核间麻痹。
Neurology. 2019 May 14;92(20):e2299-e2308. doi: 10.1212/WNL.0000000000007499. Epub 2019 Apr 19.
3
Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score.多发性硬化症中核间性眼肌麻痹的定量眼动图特征:版本性眼球运动失调指数Z评分
J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):51-5. doi: 10.1136/jnnp.73.1.51.
4
Identification of internuclear ophthalmoplegia signs in multiple sclerosis patients. Saccade test analysis.多发性硬化症患者核间性眼肌麻痹体征的识别。扫视试验分析。
J Neurol. 2008 Jul;255(7):1006-11. doi: 10.1007/s00415-008-0819-5. Epub 2008 May 2.
5
A new measure of dysconjugacy in INO: the first-pass amplitude.一种新的核间性眼肌麻痹中眼球运动失调的测量方法:首过振幅。
J Neurol Sci. 2003 Jun 15;210(1-2):65-71. doi: 10.1016/s0022-510x(03)00027-3.
6
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial.多发性硬化症核间性眼肌麻痹的治疗:一项随机、双盲、安慰剂对照交叉试验。
CNS Neurosci Ther. 2019 Jun;25(6):697-703. doi: 10.1111/cns.13096. Epub 2019 Feb 12.
7
Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.多发性硬化症中临床检测核间性眼肌麻痹的准确性:与定量红外眼动图的对照
Neurology. 2003 Sep 23;61(6):848-50. doi: 10.1212/01.wnl.0000085863.54218.72.
8
Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.对患有核间性眼肌麻痹的多发性硬化症患者的Uhthoff现象进行建模。
Neurology. 2008 Mar 25;70(13 Pt 2):1098-106. doi: 10.1212/01.wnl.0000291009.69226.4d. Epub 2008 Feb 20.
9
Saccadic delay in multiple sclerosis: A quantitative description.多发性硬化症中的眼跳延迟:定量描述。
Vision Res. 2020 Mar;168:33-41. doi: 10.1016/j.visres.2020.01.003. Epub 2020 Feb 14.
10
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis.基于模型的研究:多发性硬化症中的核间性眼肌麻痹和眼运动疲劳。
Prog Brain Res. 2019;249:329-344. doi: 10.1016/bs.pbr.2019.04.021. Epub 2019 Jun 6.

引用本文的文献

1
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress.识别多发性硬化症中再髓鞘化和恢复的生物标志物:进展的衡量标准。
Biomedicines. 2025 Feb 4;13(2):357. doi: 10.3390/biomedicines13020357.
2
Measuring and predicting the effect of remyelinating therapy in multiple sclerosis: a randomised controlled trial protocol (RESTORE).测量和预测多发性硬化症髓鞘修复治疗效果的随机对照试验方案(RESTORE)。
BMJ Open. 2024 Jan 30;14(1):e076651. doi: 10.1136/bmjopen-2023-076651.
3
A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis.
非裔美国人和西班牙裔多发性硬化症患者神经眼科疾病的叙述性综述。
Ther Adv Chronic Dis. 2023 Sep 30;14:20406223231202645. doi: 10.1177/20406223231202645. eCollection 2023.
4
A Stroke of Vision as One-and-a-Half Syndrome: Is It Time to Update the FAST Criteria and ABCD2 Score?作为一种“一个半综合征”的视觉发作:是时候更新FAST标准和ABCD2评分了吗?
Cureus. 2022 Sep 20;14(9):e29370. doi: 10.7759/cureus.29370. eCollection 2022 Sep.